Enables a group of researchers at the Institute of World Health at the University of Notre Dame in the United States of America to develop new genetic segment to identify the mechanism that causes the human body to cause resistance to malaria drugs, so as to change treatment plans used to become more feasible in the treatment of disease.
The findings come in a recent study published the journal "Science", and the number issued in the fifth month of April.
The drug "Artemisinin" A natural medicines used to treat malaria, is extracted from a plant which has been used in China for centuries, but the property is suffering from a process resistance to it from the human body in the final stages of the steps work, which makes the detection of the cause of resistance body to these drugs is very necessary.
And successful researchers in the development of chip new genetic given genetic analysis full of blood samples of patients of malaria, where a thorough examination of nearly than 7000 Khkhal possible Balnyukluotadat own DNA into the genome of the parasite, and give detailed data around, which gives doctors the ability to understand the handling of medicines with the parasite is highly resistant, and then the ability to choose the best therapeutic solutions to deal with it.
Posts
0 التعليقات:
Post a Comment